SAG

SageView Advisory Group Portfolio holdings

AUM $2.96B
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+15.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.96B
AUM Growth
+$59.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,619
New
Increased
Reduced
Closed

Top Sells

1 +$13.7M
2 +$11.7M
3 +$9.69M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$8.01M
5
PDEC icon
Innovator US Equity Power Buffer ETF December
PDEC
+$7.73M

Sector Composition

1 Technology 6.54%
2 Financials 3.01%
3 Healthcare 2.73%
4 Industrials 2.12%
5 Consumer Discretionary 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCE icon
2426
1st Source
SRCE
$1.82B
$625 ﹤0.01%
+10
XTIA icon
2427
XTI Aerospace
XTIA
$88.9M
$620 ﹤0.01%
+500
TRVI icon
2428
Trevi Therapeutics
TRVI
$1.96B
$614 ﹤0.01%
+49
BBW icon
2429
Build-A-Bear
BBW
$506M
$613 ﹤0.01%
+10
NRIX icon
2430
Nurix Therapeutics
NRIX
$1.81B
$608 ﹤0.01%
+32
QS icon
2431
QuantumScape Corp
QS
$4.35B
$606 ﹤0.01%
+58
CLS icon
2432
Celestica
CLS
$45.5B
$592 ﹤0.01%
+2
COCO icon
2433
Vita Coco
COCO
$2.76B
$584 ﹤0.01%
+11
CAPR icon
2434
Capricor Therapeutics
CAPR
$2.01B
$578 ﹤0.01%
+20
AER icon
2435
AerCap
AER
$24B
$576 ﹤0.01%
+4
EOSE icon
2436
Eos Energy Enterprises
EOSE
$2.43B
$573 ﹤0.01%
+50
YOU icon
2437
Clear Secure
YOU
$5.27B
$562 ﹤0.01%
+16
CLLS
2438
Cellectis
CLLS
$445M
$557 ﹤0.01%
+115
CRCL
2439
Circle Internet Group
CRCL
$26.2B
$556 ﹤0.01%
+7
BDN
2440
Brandywine Realty Trust
BDN
$514M
$541 ﹤0.01%
+185
LTH icon
2441
Life Time Group Holdings
LTH
$6.36B
$532 ﹤0.01%
+20
VKTX icon
2442
Viking Therapeutics
VKTX
$4.08B
$528 ﹤0.01%
+15
CRON
2443
Cronos Group
CRON
$1.02B
$526 ﹤0.01%
+200
SAIL
2444
SailPoint Inc
SAIL
$6.52B
$526 ﹤0.01%
+26
SVV icon
2445
Savers
SVV
$1.34B
$524 ﹤0.01%
+56
HNST icon
2446
The Honest Company
HNST
$380M
$516 ﹤0.01%
+200
HPP
2447
Hudson Pacific Properties
HPP
$409M
$510 ﹤0.01%
+47
APPS icon
2448
Digital Turbine
APPS
$450M
$500 ﹤0.01%
+100
SR icon
2449
Spire
SR
$5.46B
$497 ﹤0.01%
+6
RAPP
2450
Rapport Therapeutics
RAPP
$1.9B
$486 ﹤0.01%
+16